Our services

We are a boutique consultancy specialized in therapy development for epilepsy and rare neurodevelopmental disorders. We have supported over 20 clients in this space with the following services:

1. Pipeline and Portfolio Strategy

We help biopharma companies make smarter portfolio decisions by identifying the most promising opportunities and de-risking early investments. Whether you’re scouting assets to in-license, selecting the right indications, or evaluating academic programs for new company creation, we provide the strategic insights that ensure your pipeline is positioned for long-term success.

  • Asset scouting and in-licensing support

  • Indication selection and expansion strategy

  • Competitive and disease landscape intelligence

  • Portfolio prioritization for investors, incubators, and pharma

2. Clinical and Regulatory Development Support

From preclinical models to regulatory interactions, we bridge the gap between science and strategy. We partner with R&D teams to design robust preclinical and clinical programs, define outcome measures that matter to regulators and patients, and prepare for EMA/FDA regulatory pathways. Our work supports internal decision-making and accelerates time to clinic and market.

  • Preclinical model design and interpretation

  • Clinical trial design, outcome measures, and SoC benchmarking

  • EMA/FDA regulatory strategy

  • Market access planning and competitor scenario analysis

  • Internal communication around program value

3. Medical Affairs, Communications and Patient Engagement

We help companies build credibility and trust with patients, clinicians, and regulators. From shaping advisory boards to developing patient-facing materials and publications, our work ensures your science is communicated clearly and strategically. By aligning medical affairs, corporate communications, and patient partnerships, we amplify the impact of your programs and prepare the ground for successful commercialization.

  • KOL engagement and medical advisory boards

  • Patient partnership models and communication strategy

  • Clinical and educational materials for HCPs and patients

  • Corporate communications support for clinical and marketed products

  • Publications (guidelines, burden of disease, outcomes research)